Dr David JamiesonResearch Associate
Email: david.jamieson@ncl.ac.uk Telephone: +44 (0) 191 246 4441 Address: Northern Institute for Cancer Research
Cresti N, Jamieson D. The pharmacology of trastuzumab and its use in breast cancer .2 , 149-165.
Bray J, Sludden J, Griffin MJ, Cole M, Verrill M, Jamieson D, Boddy AV. Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide .
British Journal of Cancer 2010, 102 (6), 1003-1009.
Jamieson D, Cresti N, Verrill MW, Boddy AV. Development and validation of cell-based ELISA for the quantification of trastuzumab in human plasma .
Journal of Immunological Methods 2009, 345 (1-2), 106-111.
Weatherhead SC, Jamieson D, Reynolds NJ. Real-time imaging of ultraviolet B-induced keratinocyte apoptosis to determine duration of apoptosis and effect on tissue turnover .
In: British Journal of Dermatology: Annual Meeting of the British Society for Investigative Dermatology . 2009, Royal Agricultural College, Cirencester, UK: Wiley-Blackwell.
Jamieson D. Mitomycin C .
In: Schwab, M., ed. Encyclopedia of Cancer . Berlin: Springer-Verlag, 2008.
Jamieson D, Wilson K, Pridgeon S, Margetts J, Edmondson R, Leung H, Knox R, Boddy AV. NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism .
Clinical Cancer Research 2007, 13 (5), 1584-1590.
Jamieson, D., Tung, A., Knox, R., Boddy, A. Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor .
British Journal of Cancer 2006, 95 (9), 1229-1233.
Weatherhead SC, Jamieson D, Reynolds NJ. Real time imaging of UVB-induced keratinocyte apoptosis, and analysis of factors influencing cell-to-cell variation .
In: Journal of Investigative Dermatology: 39th Annual Meeting of the European Society for Dermatological Research (ESDR) . 2009, Budapest, Hungary: Nature Publishing Group.
Armstrong JL, Martin S, Illingworth NA, Jamieson D, Neilson A, Lovat PE, Redfern CPF, Veal GJ. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide .
Oncology Reports 2012, 27 (1), 293-298.
Weatherhead S, Farr P, Swan D, Jamieson D, Hallinan J, Lloyd J, Wipat A, Reynolds N. Apoptosis of keratinocytes is a key mechanism in UVB-induced clearance of psoriasis .
In: Journal of Investigative Dermatology: 41st Annual Meeting of the European Society for Dermatological Research . 2011, Barcelona, Spain: Nature Publishing Group.
Weatherhead SC, Farr PM, Jamieson D, Hallinan JS, Lloyd JL, Wipat A, Reynolds NJ. Keratinocyte Apoptosis in Epidermal Remodeling and Clearance of Psoriasis Induced by UV Radiation .
Journal of Investigative Dermatology 2011, 131 (9), 1916-1926.
Jamieson D, Boddy AV. Pharmacogenetics of genes across the doxorubicin pathway .
Expert Opinion on Drug Metabolism and Toxicology 2011, 7 (10), 1201-1210.
Jamieson D, Cresti N, Bray J, Sludden J, Griffin MJ, Hawsawi NM, Famie E, Mould EVA, Verrill MW, May FEB, Boddy AV. Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy .
Pharmacogenetics and Genomics 2011, 21 (12), 808-819.
